Targeting Novel Molecular Mechanisms May Repair Damaged DNA - News CenterEZH2 protein dysregulates PARP1 activity, leading to impaired DNA repair in prostate cancer, informing potential targeted therapies for resistant cases.
Author Correction: Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells - NatureCollaboration across institutions leads to significant advancements in cancer treatment and research.
Scientists Discover Potential Biomarker in Rare Skin Cancer - News CenterIncreased immune cell activity in Merkel cell carcinoma tumors could predict treatment response and aid in developing targeted therapies.
Blood test reveals best lung cancer treatmentBlood test for lung cancer patients in England to guide targeted therapiesGenetic variations can lead to personalized treatment decisionsTargeted drug brigatinib prescribed based on mutation in ALK gene